Marktgröße, Marktanteil und Trendanalyse für Lösungen zur Analyse klinischer Daten nach Bereitstellungsmodus (On-Premise, Cloud-basiert), Anwendung (Klinische Entscheidungsunterstützung, Klinische Studien, Einhaltung regulatorischer Bestimmungen) und Region (Nordamerika, Europa, Asien-Pazifik, Naher Osten und Afrika, Lateinamerika) – Prognosen für 2024–2032

Market dynamics

Drivers of the global clinical data analytics solutions market:

Increasing volume of clinical data

The exponential growth of clinical data from electronic health records (EHRs), medical imaging, genome sequencing, wearables, and other sources necessitates advanced analytics solutions to manage and evaluate these massive datasets. The increasing adoption of EHR systems in healthcare has resulted in a tremendous influx of digitized patient data. According to healthit.gov, by 2021, 96% of non-federal acute care hospitals in the U.S. will have implemented a certified EHR system—an increase in just ten years from 34% in 2011. A 2023 study found that the adoption of basic EHR systems increased from 6.6% to 81.2%, while the adoption of comprehensive systems grew from 3.6% to 63.2%.

Furthermore, the widespread use of medical imaging technologies such as MRI, CT, and X-rays generates enormous amounts of digital image data. For example, a single CT scan can generate hundreds of images, contributing to the overall volume of clinical data. Similarly, advances in genomics and genetic testing technology have enabled the acquisition of vast amounts of genomic data for precision medicine projects and research studies. For instance, the cost of genome sequencing has decreased significantly over time, making it more accessible. In 2023, the cost of sequencing a human genome is projected to be around $600, compared to $10,000 ten years earlier. This is a remarkable achievement considering that the Human Genome Project (HGP) initially cost $2.7 billion to map the genome over two years.

Angesichts der rasant wachsenden Menge klinischer Daten müssen Gesundheitsunternehmen zudem ausgefeilte Analyselösungen implementieren, um diese riesigen Datensätze adäquat zu verwalten, zu analysieren und daraus Erkenntnisse zu gewinnen. Klinische Datenanalyselösungen nutzen Data Warehousing, Business Intelligence und künstliche Intelligenz, um handlungsrelevante Erkenntnisse zu gewinnen, die die Patientenversorgung verbessern, klinische Arbeitsabläufe optimieren und die Behandlungsergebnisse im Gesundheitswesen steigern.

Hemmnisse auf dem globalen Markt für klinische Datenanalyselösungen:

Bedenken hinsichtlich des Datenschutzes

Organisationen im Gesundheitswesen müssen strenge Gesetze und Compliance-Anforderungen zum Schutz der Patientendaten einhalten, wie beispielsweise HIPAA in den USA und die DSGVO in der EU. Bedenken hinsichtlich Datenschutzverletzungen, unrechtmäßigem Zugriff und Missbrauch von Patientendaten können die Einführung klinischer Datenanalyselösungen, insbesondere cloudbasierter Plattformen, die Datenaustausch und -speicherung erfordern, behindern. Laut dem IBM-Bericht „Cost of a Data Breach Report 2023“ beliefen sich die durchschnittlichen Kosten einer Datenschutzverletzung weltweit im Jahr 2023 auf 4,45 Millionen US-Dollar, ein Anstieg von 15 % gegenüber 2020. Dies ist der höchste jemals verzeichnete Wert. Der Analyse zufolge werden die durchschnittlichen Kosten einer Datenschutzverletzung im Jahr 2023 um 2,25 % höher liegen als im Jahr 2022, als sie 4,35 Millionen US-Dollar betrugen. Im Mai 2023 informierte IBM HCPF über den Vorfall, der zu einem unrechtmäßigen Zugriff auf die Sozialversicherungsnummern, Identitäten, medizinischen Daten und Gesundheitsinformationen von über 4 Millionen Leistungsempfängern geführt hatte.

Darüber hinaus verzeichnete der Gesundheitssektor im Jahr 2023 die längste durchschnittliche Dauer von Datenschutzverletzungen: Die Eindämmung dauerte 92 Tage, verglichen mit 73 Tagen in anderen Branchen. Auch die Anzahl der Datenschutzverletzungen war im Gesundheitssektor mit 725 Hackerangriffen, die zum Verlust von über 124 Millionen Patientendatensätzen führten, am höchsten. Diese Statistiken verdeutlichen die gravierenden finanziellen und reputationsbezogenen Folgen von Datenschutzverletzungen im Gesundheitswesen. Da Gesundheitsunternehmen klinische Datenanalyselösungen zur Verbesserung der Patientenversorgung und der betrieblichen Effizienz einsetzen, ist die Behebung von Datenschutz- und Sicherheitsbedenken entscheidend für das Vertrauen, die Einhaltung von Vorschriften und die effektive Nutzung von Analyselösungen.

Marktchancen für globale Lösungen zur klinischen Datenanalyse:

Integration von künstlicher Intelligenz und maschinellem Lernen

The integration of artificial intelligence (AI) and machine learning (ML) algorithms into clinical data analytics solutions opens up promising perspectives for improving predictive analytics, anomaly detection, and pattern recognition. AI-powered analytics systems can automate data processing, uncover hidden correlations, and extract actionable insights from large clinical datasets. This leads to more precise diagnoses, optimized treatment planning, and improved disease management.

A study published in JAMA Network Open also showed that AI algorithms can improve diagnostic accuracy and treatment outcomes in radiology. The study found that an AI system developed by Google Health outperformed radiologists in diagnosing breast cancer from mammograms, reducing the false-positive and false-negative rates by 5.7% and 9.4%, respectively. These results highlight how AI-powered systems for analyzing clinical data can improve diagnostic accuracy, patient safety, and the quality of healthcare.

An analysis by McKinsey & Company also shows that AI applications in healthcare could generate an annual value of $200 billion in the US alone. This is due to advances in diagnosis and treatment, increased operational efficiency, and savings in administrative costs. AI-powered systems for analyzing clinical data have the potential to fundamentally transform healthcare, enabling more precise, personalized, and proactive care, while simultaneously reducing healthcare inequalities and improving patient outcomes.

Anpassung anfordernum einen maßgeschneiderten Bericht zu erhalten.

Segment analysis

The global market for clinical data analytics solutions is segmented by area of ​​application and use case.

The market is further segmented by deployment in cloud-based and on-premises areas.

The cloud sector dominated the market in 2023 with a 60% revenue share and is expected to be the fastest-growing sector throughout the forecast period. Cloud-based deployments offer solutions for clinical data analytics on remote servers over the internet, accessible to users via web browsers or application interfaces. Cloud-based deployments provide scalability, flexibility, and accessibility, enabling healthcare organizations to quickly deploy and expand analytics systems without significant upfront infrastructure investments. Internet access allows seamless access to data and analytics tools from anywhere and with any device, facilitating collaboration, remote work, and real-time decision-making.

Furthermore, cloud-based systems often incorporate advanced security measures and data encryption techniques to ensure the confidentiality, integrity, and availability of critical health data. The growth of this segment is driven by the scalability benefits for healthcare organizations, enabling them to adapt their analytics infrastructure to evolving data needs.

On-premises deployment involves hosting clinical data analytics tools within the organization's physical infrastructure, including servers and data centers located on-site at the healthcare facility. This solution offers healthcare organizations greater control over data governance, security, and customization options, as they own and manage the hardware, software, and data resources. However, on-premises deployment often requires higher initial investments, longer implementation times, and ongoing maintenance and support costs. Scaling the infrastructure to accommodate growing data volumes and evolving analytics needs can also be more complex than the scalability and agility of cloud-based solutions.

The market for clinical data analytics solutions can be divided into two parts,  depending on the application, into the areas of clinical decision support, clinical trials, and regulatory compliance.

The clinical trials sector held the largest market share for clinical data analytics solutions, reflecting a growing awareness of the benefits of these solutions in this context. Clinical data analytics solutions are essential for the design, execution, and analysis of clinical trials to evaluate the safety and efficacy of new drugs, medical devices, and therapies. These systems enable researchers to capture, standardize, and analyze data from various sources, including electronic health records, laboratory findings, and patient-reported outcomes. By employing sophisticated analytical methods such as predictive modeling and real-world evidence analysis, clinical trials can be conducted more efficiently, leading to improved patient recruitment, protocol adherence, and better study results.

Furthermore, the increasing number of clinical trials, driven by the need for technologically improved and cost-effective medical treatments, is a significant incentive. According to a WHO study published in February 2023, the total number of clinical trials rose from 51,451 in 2017 to 54,954 in 2022.

Clinical decision support systems (CDS) are expected to experience the fastest growth during the forecast period. CDS systems utilize clinical data analytics to provide healthcare professionals with relevant insights and evidence-based recommendations directly during treatment. These solutions use patient data, medical literature, and best practices to support physicians in diagnosing diseases, selecting appropriate therapies, and improving treatment outcomes. CDS solutions help reduce medical errors, improve the quality of care, and optimize treatment plans by combining patient-specific data with clinical guidelines and knowledge resources.

Furthermore, the growth of this segment is driven by the increasing use of clinical decision support systems (CDS), which tailor recommendations and treatment plans to individual patient profiles. Clinical data analytics solutions are essential for improving CDS, as they provide physicians with patient-specific information and enable targeted and successful therapies. These technologies also include AI and machine learning in CDS applications, which deliver predictive insights for early detection and treatment planning. These factors are expected to further fuel the growth of this segment during the forecast period.

Mit einem Analysten sprechenum Marktchancen zu besprechen.

Regional analysis

The market analysis for clinical data analysis solutions worldwide is conducted in North America, Europe, Asia-Pacific, the Middle East and Africa, and Latin America.

North America dominates the world market

North America is the world's leading market player in clinical data analytics solutions and is projected to grow at a compound annual growth rate (CAGR) of 26.6% during the forecast period. North America dominated the market in 2023, accounting for 43.66% of total revenue. This is attributable to the region's well-developed healthcare infrastructure and the widespread adoption of modern technologies. The increasing prevalence of chronic diseases and the aging population are driving regional healthcare providers to implement analytics solutions. Furthermore, the presence of major industry players contributes to market growth. According to ClinicalTrials.gov, the United States accounted for 34% of all registered clinical trials in 2022. Data from various sources must be reviewed and analyzed to develop successful population health management plans.

According to the same source, 37% of all globally registered clinical trials with recruitment took place in the USA. New Medicare regulations from the US government threaten hospitals and physicians with financial penalties for failing to use electronic health records (EHRs). Although the US has long been considered a leader in the application of innovative technologies in patient care, physicians and hospitals have had to rapidly transition to electronic records. These initiatives aim to improve the usability of electronic health records. The implementation of these new regulations will increase the demand for clinical data analytics solutions in the region.

Europe is expected to experience average annual growth of 26.9% over the forecast period. Europe is projected to see the strongest growth during this time. This expansion is driven by interoperability measures, which are crucial in a region with diverse and often fragmented healthcare systems. The European healthcare sector is increasingly relying on AI and machine learning, particularly in radiology and pathology, to rapidly analyze large datasets. Governments are also investing in digital health infrastructure and promoting clinical data analytics solutions to improve access to healthcare, reduce costs, and optimize patient outcomes.

Furthermore, the demand for medical supplies, equipment, information technology, and support services is steadily increasing. Forecasts indicate that the need for data management in the UK healthcare system has grown rapidly over the past two years, leading to the construction of numerous new hospitals, COVID-19 testing centers, and healthcare-focused transport infrastructure.

As a result, a huge amount of unstructured data, such as patient information, data on coronavirus survivors, associated deaths, administered vaccines, infection rates and a host of other data, prompted medical professionals to use clinical data analytics technologies.

The Asia-Pacific region is likely to be the fastest-growing market. Rising healthcare spending, rapid digitalization, and a growing awareness of the importance of a strengthened healthcare infrastructure in countries like China and India are driving market growth. This increasing awareness, the large number of patients, and the use of advanced technologies are key contributors to the region's high growth potential.

Furthermore, there is a growing desire in India to reduce healthcare costs and improve patient outcomes. All of this paves the way for the use of big data in the Indian healthcare system, where such information can be rapidly analyzed and decisions made based on vast amounts of data.

Regionale Einblicke freischaltenum auf länderspezifische Daten und regionale Trends zuzugreifen.